OBJECTIVE: To assess the seroprevalence and risk factors for HTLV-I infection in Peruvian women. METHODS: Five hundred and sixty-eight healthy women >20 years of age from three Peruvian regions were randomly selected and screened for HTLV-I. ELISA-reactive sera were confirmed via immunofluorescence assay, recombinant immunoblot assay, Western blot, and PCR. Women from Huanta (n=303), an Andean city inhabited by indigenous Quechuans, El Carmen (n=132), a primarily African-American coastal town, and Lima (n=133), with its Mestizo population, were selected. RESULTS: HTLV-I antibodies were present in 2.5% (14/568) of women (1.3% in Huanta, 3.8% in El Carmen, and 3.8% in Lima); 2.5%, 2.7% and 2.6% of Quechuans, Mestizas and African-Americans, respectively, were infected. History of a blood transfusion (P <0.00002), chronic scabies (P <0.02), having a relative with leukemia (P <0.04), age +/- 38 years (P <0.03), young age at first intercourse (P <0.04), lifetime partners >4 (P <0.04), educational status (P <0.02) and >4 pregnancies (P <0.03) were significantly associated with infection. CONCLUSIONS: HTLV-I is endemic among asymptomatic Peruvian women. Parenteral, vertical and heterosexual transmission are associated with infection.
OBJECTIVE: To assess the seroprevalence and risk factors for HTLV-I infection in Peruvian women. METHODS: Five hundred and sixty-eight healthy women >20 years of age from three Peruvian regions were randomly selected and screened for HTLV-I. ELISA-reactive sera were confirmed via immunofluorescence assay, recombinant immunoblot assay, Western blot, and PCR. Women from Huanta (n=303), an Andean city inhabited by indigenous Quechuans, El Carmen (n=132), a primarily African-American coastal town, and Lima (n=133), with its Mestizo population, were selected. RESULTS:HTLV-I antibodies were present in 2.5% (14/568) of women (1.3% in Huanta, 3.8% in El Carmen, and 3.8% in Lima); 2.5%, 2.7% and 2.6% of Quechuans, Mestizas and African-Americans, respectively, were infected. History of a blood transfusion (P <0.00002), chronic scabies (P <0.02), having a relative with leukemia (P <0.04), age +/- 38 years (P <0.03), young age at first intercourse (P <0.04), lifetime partners >4 (P <0.04), educational status (P <0.02) and >4 pregnancies (P <0.03) were significantly associated with infection. CONCLUSIONS:HTLV-I is endemic among asymptomatic Peruvian women. Parenteral, vertical and heterosexual transmission are associated with infection.
Authors: Joseph R Zunt; Alberto M La Rosa; Jesús Peinado; Javier R Lama; Luis Suarez; Monica Pun; Cesar Cabezas; Jorge Sanchez Journal: Am J Trop Med Hyg Date: 2006-05 Impact factor: 2.345
Authors: Jenell Stewart; Kristen Heitzinger; Simon Pollett; Martha Calderón; Jorge Alarcón; Thanh G N Ton; Joseph R Zunt Journal: Am J Trop Med Hyg Date: 2016-11-22 Impact factor: 2.345
Authors: Jorge O Alarcón; Heidi B Friedman; Silvia M Montano; Joseph R Zunt; King K Holmes; Gerald V Quinnan Journal: J Acquir Immune Defic Syndr Date: 2006-08-15 Impact factor: 3.731
Authors: I Best; V Adaui; K Verdonck; E González; M Tipismana; D Clark; E Gotuzzo; G Vanham Journal: Clin Exp Immunol Date: 2006-11 Impact factor: 4.330
Authors: Isaac E Alva; E Roberto Orellana; Magaly M Blas; Antonio Bernabe-Ortiz; Armando Cotrina; Marina Chiappe; Tadeusz J Kochel; Cesar P Carcamo; Patricia J García; Joseph R Zunt; Anne L Buffardi; Silvia M Montano Journal: Am J Trop Med Hyg Date: 2012-09-10 Impact factor: 2.345
Authors: Magaly M Blas; Isaac E Alva; Patricia J García; Cesar Cárcamo; Silvia M Montano; Nicanor Mori; Ricardo Muñante; Joseph R Zunt Journal: PLoS One Date: 2013-09-05 Impact factor: 3.240